As the past decade barely dawned, a fundamentally novel view of cancer relating to signal transduction through intracellular hormones/growth factors and their subunits began to unfold. Further along, it gained additional substance with the advent of the interdisciplinary fields of particle biology and peptide strings which explain (onco)protein dynamics in spacetime, for instance insulin-driven sub- and trans-cellular carcinogenesis, by physical principles. Here, this new understanding is expanded to introduce the concept of "oncoprotein metastasis" preceding cancer cell spread and, thereby, a particular emphasis is placed on its potential role in the emergence of the pre-metastatic niche. Consistent with this perception, yet unlike currently advocated treatments that target cancer cells only, future antineoplastic strategies should aim to mimic natural tumor suppressors as well as involve both (morphologically) normal and malignant cells. If validated in human patients with advanced cancer disease, its otherwise frequently lethal course may be halted and reversed just in time.
Deep Dive into Oncoprotein metastasis disjoined.
As the past decade barely dawned, a fundamentally novel view of cancer relating to signal transduction through intracellular hormones/growth factors and their subunits began to unfold. Further along, it gained additional substance with the advent of the interdisciplinary fields of particle biology and peptide strings which explain (onco)protein dynamics in spacetime, for instance insulin-driven sub- and trans-cellular carcinogenesis, by physical principles. Here, this new understanding is expanded to introduce the concept of “oncoprotein metastasis” preceding cancer cell spread and, thereby, a particular emphasis is placed on its potential role in the emergence of the pre-metastatic niche. Consistent with this perception, yet unlike currently advocated treatments that target cancer cells only, future antineoplastic strategies should aim to mimic natural tumor suppressors as well as involve both (morphologically) normal and malignant cells. If validated in human patients with advanced c
Radulescu
Sub-cellular cancer metastasis and its therapy
arXiv December 18, 2007
Oncoprotein Metastasis
Disjoined
Razvan Tudor Radulescu
Molecular Concepts Research (MCR), Munich, Germany
E-mail: ratura@gmx.net
ABSTRACT
As the past decade barely dawned, a fundamentally novel view of cancer relating to
signal transduction through intracellular hormones/growth factors and their
subunits began to unfold. Further along, it gained additional substance with the
advent of the interdisciplinary fields of particle biology and peptide strings which
explain (onco)protein dynamics in spacetime, for instance insulin-driven sub- and
trans-cellular carcinogenesis, by physical principles. Here, this new understanding is
expanded to introduce the concept of “oncoprotein metastasis” preceding cancer cell
spread and, thereby, a particular emphasis is placed on its potential role in the
emergence of the pre-metastatic niche. Consistent with this perception, yet unlike
currently advocated treatments that target cancer cells only, future antineoplastic
strategies should aim to mimic natural tumor suppressors as well as involve both
(morphologically) normal and malignant cells. If validated in human patients with
advanced cancer disease, its otherwise frequently lethal course may be halted and
reversed just in time.
Keywords:
cell biology, cancer, oncoprotein, metastasis, physics, string theory, particle
biology, peptide strings, retinoblastoma protein (RB), growth factor, hormone,
subunit, insulin, hyperinsulinemia, nucleocrine signal transduction, cell-
permeable tumor suppressor peptides
Radulescu
Sub-cellular cancer metastasis and its therapy
arXiv December 18, 2007
- 2 -
A huge amount of experimental data
relating
to
the
problem
of
cancer
metastasis
has
accumulated
(1).
By
contrast,
concepts
providing
a
basic
interpretation of these observations have
been few. Here, a new scenario is put
forward on the spreading of the neoplastic
process across cells and tissues that may
prove
seminal
both
for
our
future
understanding
and
treatment
of
malignancies.
Currently, three major views serve
to explain both the emergence of cancer
and its metastatic spread. One of these
frameworks is the (cellular) oncogene
theory developed by Michael Bishop and
Harold Varmus along with Dominique
Stehelin in the early 1970s and still
prevailing to date (2). It assumes an
overactivity of oncogenes (through gene
amplification and/or mutation) being at
the root of neoplastic transformation and
cancer cell spread.
Another mechanism proposed to
initiate and expand primary tumors as well
as trigger its associated metastasis is the
loss of (individual) tumor suppressor
activity, a proposal that, in its essence, can
be traced back to Theodor Boveri as well as
later on to Alfred Knudson´s two-hit
hypothesis and is best exemplified by the
first discovered tumor suppressor gene Rb
(3,4). This tumor suppressor dysfunction
that is thought to decisively contribute to
carcinogenesis can occur at the level of the
genes, but, at least as far as the key tumor
suppressor retinoblastoma protein (RB) is
concerned, is found even more frequently
at the protein level in the form of post-
translational modifications (5).
Thirdly and in more recent years,
chromosomal abnormalities resulting in
aneuploidy have emerged as another
important potential origin for cancer
(metastasis), mainly through the work of
Peter Duesberg and his associates (6).
Yet,
genetic
and
chromosomal
views
of
cancer
are
not
entirely
satisfactory.
For
instance,
Richmond
Prehn raised already in 1994 the question
as to whether mutations found in some
genes of cancer cells may be rather an
epiphenomenon
accompanying
the
(already initiated) neoplastic process than
a causative event (7). Along the same lines,
Judah Folkman and coworkers have also
appealed to (additionally) go outside the
cancer
genome
(8)
to
find
broader
answers, one direction being traced by his
long-standing idea on tumor angiogenesis
(9). Nevertheless, such example may be
understood just as an incentive to embark
upon
a
multidirectional
conceptual
journey
beyond
the
genome
that
altogether
should
yield
the
ultimate
solution to the cancer problem.
In this context, my peptide string
theory (10-12) is likely to represent a
significant addition. It rests upon the
assumption according to which major
biological processes concerning distinct,
yet related proteins are the result both of
(long-distance) attractive forces in the
sense of the physical string theory (13,14)
and of “emergent properties” inherent to
the same proteins whereby the term
Radulescu
Sub-cellular cancer metastasis and its therapy
arXiv December 18, 2007
- 3 -
“emergent”
is
to
be
understood
as
employed by John Searle in his book
entitled “The Mystery of Consciousness”
wher
…(Full text truncated)…
This content is AI-processed based on ArXiv data.